July 11, 2014 7:43 AM ET

Electronic Equipment, Instruments and Components

Company Overview of BiOptix Inc.

Company Overview

BiOptix Inc., an analytical instrumentation company, develops an array-based bio molecule detection systems and molecular interaction analysis instruments. The company’s products pipeline includes cell array biodetector systems, and biochip and optical cartridges; and pre-production small footprint and single cell biodetector systems. Its products are used to detect various molecules and micro organisms, including micro RNA, nucleic acids, proteins and antibodies, bacteria, viruses, carbohydrates, lipids, and low molecular weight drugs. The company serves clinical biomarkers and diagnostics, personalized medicine, infectious disease, drug discovery, biopharma and low molecular drug developme...

1775 38th Street

Suite A

Boulder, CO 80301

United States

Founded in 2003

Phone:

303-545-5550

Fax:

303-545-5551

Key Executives for BiOptix Inc.

Chief Executive Officer
Co-Founder and Director of Research and Development
Chief Financial Officer
Chief Scientific Officer
Vice President of Sales and Marketing
Compensation as of Fiscal Year 2014.

BiOptix Inc. Key Developments

BiOptix Announces Low Cost Surface Plasmon Resonance Services for Colorado-Based Researchers

BiOptix formally announced a unique to the industry research collaboration with the Biophysics Shared Resource Core Facility at the University of Colorado Denver, Anschutz Medical Campus. The collaboration, which is supported by BiOptix, is offering low cost SPR services for Colorado-based researchers on the new BiOptix 404pi, a next-generation surface plasmon resonance platform designed and built in Colorado. The BiOptix 404pi provides label-free analysis of protein-protein kinetics as well as protein-small molecule interactions. The Biophysics Shared Resource Facility is a user facility owned and operated by the Program in Structural Biology and Biochemistry at the University of Colorado, Denver. Since opening in 2001, the group has developed resources to study biomolecular structure and thermodynamics through surface plasmon resonance, CD/ORD, ITC, DSC, fluorescence spectroscopy, and analytical ultracentrifugation (AUC). In addition, the group also offers mass spectroscopy, LC/MS/MS, HPLC and amino acid analysis services. Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

BiOptix to Highlight New Carbonic Anhydrase Data at IBC's Biopharmaceutical Development & Production Week

BiOptix is highlighting new and compelling small molecule kinetics data from the new BiOptix 404pi at the IBC Biopharmaceutical Development & Production Week to be held from February 25 -- March 1 2013 in Huntington Beach, CA. These new data sets continue to underscore the versatility of the BiOptix 404pi, an SPR instrument that is built for both protein-protein kinetics as well as protein-small molecule interactions. Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

BiOptix Inc. to Highlight New 404pi Instrument at European Symposia

BiOptix Inc. announced that it would be highlighting the new BiOptix 404pi, the first commercially available SPR instrument to incorporate phase-based common path interferometry technology, at the Label Free Technologies Show in Amsterdam from November 1 - 3 as well as at the PEGS Europe Summit on November 6 - 8. BiOptix technology allows for the simultaneous monitoring of multiple analytes in a single sample. This new class of SPR instrumentation from BiOptix has been designed to measure protein/protein and protein-small molecule interactions (down to 100 Da) in a high-throughput 96/384 well platform utilizing 4 parallel channels rather than a single flow cell. Surface Plasmon Resonance is an advanced and highly sensitive optical technology that can measure refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

Similar Private Companies By Industry

Company Name Region
Cass Creek International LLC United States
DRS Signal Technologies Inc. United States
BrandWatch Technologies, Inc. United States
Stradis, Inc. United States
Axiom Technology, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BiOptix Inc., please visit www.bioptix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.